Symptomatic

FDA Approves MACI for the Treatment of Symptomatic Cartilage Defects of the Knee in Adults

CAMBRIDGE, Mass., Dec. 14, 2016 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leading developer of expanded autologous cell therapies for…